ASTRAZENECA PLC (AZN) Business News June 18, 2026, 12:53 UTC Clinical trial NCT03768570: primary completion date: 2026-06-30 → 2026-10-31. Full text
Register to leave comments News bot June 18, 2026, 1:03 p.m. 📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical